1994
DOI: 10.1111/j.1476-5381.1994.tb17043.x
|View full text |Cite
|
Sign up to set email alerts
|

Induction of nitric oxide synthase activity in phagocytic cells inhibited by tricyclodecan‐9‐yl‐xanthogenate (D609)

Abstract: 1 The synthesis of nitric oxide (NO) by immune-stimulated murine phagocytic cells (J774) and the modulation of this synthesis by tricyclodecan-9-yl-xanthogenate (D609), a specific inhibitor of phosphatidylcholine-specific phospholipase C (PC-PLC), was investigated. D609 dose-dependently suppressed production of NO, as measured by the release of nitrite and nitrate, in response to lipopolysaccharide (LPS) and interferon-y (IFN-y) in intact cultured cells with an ICm of approximately 20 ltg ml"-'. D609 at 40 pg … Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

0
12
0

Year Published

1995
1995
2019
2019

Publication Types

Select...
7
1

Relationship

0
8

Authors

Journals

citations
Cited by 23 publications
(12 citation statements)
references
References 27 publications
0
12
0
Order By: Relevance
“…Administration was continued daily until at least 2 days after all untreated PLP-immunized mice became severely paralyzed. Tricyclodecan-9-yl-xanthogenate (D609) inhibits iNOS induction by blocking the activity of phosphatidylcholine-specific phospholipase C, a key enzyme in the signal transduction pathway leading to iNOS activation (23). Mice were given 1 mg of D609 (Biomol, Plymouth Meeting, PA), a dose which was selected as one-half the amount suspected to have toxicity based on in vitro experiments.…”
Section: Methodsmentioning
confidence: 99%
“…Administration was continued daily until at least 2 days after all untreated PLP-immunized mice became severely paralyzed. Tricyclodecan-9-yl-xanthogenate (D609) inhibits iNOS induction by blocking the activity of phosphatidylcholine-specific phospholipase C, a key enzyme in the signal transduction pathway leading to iNOS activation (23). Mice were given 1 mg of D609 (Biomol, Plymouth Meeting, PA), a dose which was selected as one-half the amount suspected to have toxicity based on in vitro experiments.…”
Section: Methodsmentioning
confidence: 99%
“…The PLC pathway plays an important role in iNOS expression in macrophages (26,27). Therefore, we examined whether PLC was involved in the prothrombin-and kringle-2-induced NO release from microglia by using the PLC inhibitors D609 (D), a phosphatidylcholine-PLC-specific inhibitor, and U-73122 (U), an inhibitor of PLC␤ and ␥.…”
Section: Inhibitors Of Pkc and Plc Reduced No Release And Tnf-␣ Mrna mentioning
confidence: 99%
“…IFN-, one of the Th1 cytokines, is a prominent cytokine in EMIU [36]. D609 inhibits the induction of iNOS in response to IFN- [12], resulting in inhibition of EMIU.…”
Section: Discussionmentioning
confidence: 99%
“…Tricyclodecan-9-yl-xanthogenate (D609) is a specific inhibitor of phosphatidylcholine-specific phospholipase C (PC-PLC), a key enzyme in the signal transduction pathway leading to iNOS activation and in the regulation of the promoter, nuclear factor-kappa B (NF-B) [12][13][14]. Therefore, D609 suppresses the induction of iNOS activation as well as TNF-induced apoptosis.…”
Section: Introductionmentioning
confidence: 99%